Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

So-Called Rare Diseases Are Too Common to Ignore

Posted on June 19th, 2017 by in Pharma R&D

It’s time to re-think our attitude towards rare diseases. Even though relatively few people suffer from any given rare disease, there are so many of these maladies that it’s a surprisingly large swath of the population that is actually victimized by them. Continue reading “So-Called Rare Diseases Are Too Common to Ignore” »

Re-Inventing R&D for Precision Medicine

Posted on May 22nd, 2017 by in Pharma R&D

Precision medicine first emerged in the late ‘90s. But it was the completion of the Human Genome Project in 2003 that really opened up a world of opportunity in this area because it became possible to test patients for certain biomarkers Continue reading “Re-Inventing R&D for Precision Medicine” »

Targeting Rare Diseases

Posted on March 20th, 2017 by in Pharma R&D

What is known as a “rare” disease might affect anywhere between a couple hundred to a couple hundred thousand people here in the U.S. And it’s estimated that as much as 10% of the nation’s population has one of the thousands of known rare diseases, most of which are genetic. Continue reading “Targeting Rare Diseases” »

Trail-blazing innovation – Seeking the new blockbuster

Posted on April 11th, 2016 by in Pharma R&D

The Holy Grail of the 21st century, at least for pharmaceutical companies, is the one blockbuster drug that will reap rewards of $1Billion+ in peak sales. Continue reading “Trail-blazing innovation – Seeking the new blockbuster” »